Comparison of short- and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis

American Journal of Cardiology

Volumn 92, Issue 6, 2003, Pages 721-725

  Le Feuvre, Claude ^a,b   Borentain, Maria ^a   Beygui, Farzin ^a   Helft, Gérard ^a   Batisse, Jean Paul ^a   Metzger, Jean Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DIABETES MELLITUS; FEMALE; HEART DEATH; HEART INFARCTION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SILENT MYOCARDIAL ISCHEMIA; TREATMENT OUTCOME;

EID: 0041333178     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00838-5     Document Type: Article

References (14)

1. Le Feuvre C., Dambrin G., Helft G., Tabet S., Beygui F., Legendre C., Péraldi M.N., Vacheron A., Metzger J.P. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol. 85:2000;1365-1368.
2. Remuzzi G., Benigni A., Schieppati A., Gotti E., Livio M., Mecca G., Donati B., de Gaetano G. Platelet function in patients on maintenance hemodialysis depressed or enhanced? Clin Nephrol. 17:1982;60-63.
3. Notohamiprodjo M., Andrassy K., Bommer J., Ritz E. Dialysis membranes and the coagulation system. Blood Purif. 4:1986;130-141.
4. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/ IIIa blockade evaluation of platelet IIb/IIIa inhibitor for stenting . Lancet. 352:1998;87-92.
5. Marso S.P., Lincoff A.M., Ellis S.G., Bhatt D.L., Tanguay J.F., Kleiman N.S., Hammoud T., Booth J.E., Sapp S.K., Topol E.J. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus. Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation. 100:1999;2477-2484.
6. Bhatt D.L., Marso S.P., Lincoff A.M., Wolski K.E., Ellis S.G., Topol E.J. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 35:2000;922-928.
7. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 345:2001;494-502.
8. Metha S.R., Yusuf S., Peters R.J., Bertrand M.E., Lewis B.S., Natarajan M.K., Malmberg K., Rupprecht H., Zhao F., Chrolavicius S., Copland I., Fox K.A. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention the PCI-CURE study . Lancet. 358:2001;527-533.
9. Steinhubl S.R., Berger B.P., Mann J.T. III, Fry E.T., DeLago A., Wilmer C., Topol E.J. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention a randomized controlled trial . JAMA. 28:2002;2411-2420.
10. Gruberg L., Dangas G., Mehran R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Lansky A.J., Stone G.W., Leon M.B. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 55:2002;66-72.
11. Koyanagi T., Nishida H., Kitamura M., Endo M., Koyanagi H., Kawaguchi M., Magosaki N., Sumiyoshi T., Hosoda S. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg. 61:1996;1793-1799.
12. Herzog C.A., Ma J.Z., Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 106:2002;2207-2211.
13. Ferguson J.J. NHLBI BARI clinical alert on diabetics treated with angioplasty. Circulation. 92:1995;3371.
14. Degertekin M., Regar E., Tanabe K., Lee C.H., Serruys P.W. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease. Minerva Cardioangiol. 50:2002;405-418.